<DOC>
	<DOCNO>NCT01579448</DOCNO>
	<brief_summary>Data demonstrate Shanchol™ ( kill bivalent oral cholera vaccine ) provide protection 3 year data regard protective efficacy five year anticipated 2012 . Regardless end five year , may still necessary provide booster dose reimmunize two dos maintain protection previously immunize population . This study examine immune protection safety provide one two dose boost regimen Shanchol™ give five year initial dose .</brief_summary>
	<brief_title>Evaluation Boosting Regimen With Oral Cholera Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Cholera</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All subject must presently enrol Phase 3 NICED RCT Shanchol™ satisfy follow criterion study entry : 1 . Male female adult age 6 year , available followup visit specimen collection . The subject able continue study next 6 week The subject ( parent/guardian ) willing provide 3 blood sample 2 . Written inform consent obtain subject parents/guardians , write assent obtain child age 12 17 year . 3 . Healthy subject determine : Medical history Physical examination Clinical judgment investigator 1. individual weak get bed receive vaccine 2. pregnant woman ( identify verbal screen ) 3. less 6 year age 4 . Receipt cholera vaccine follow 2009 ( time licensure availability Shanchol™ India )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>kill oral cholera vaccine</keyword>
	<keyword>boost vaccine regimen</keyword>
	<keyword>safety immunogenicity</keyword>
</DOC>